Name | Value |
---|---|
Revenues | 30.6K |
Cost of Revenue | 7.1K |
Gross Profit | 23.4K |
Operating Expense | 802.9K |
Operating I/L | -779.4K |
Other Income/Expense | 31.0K |
Interest Income | 8.8K |
Pretax | -748.4K |
Income Tax Expense | -38.8K |
Net Income/Loss | -709.6K |
Nexalin Technology, Inc. is a medical device company specializing in neurostimulation products for mental health treatment. Its flagship product, the Nexalin Device, offers non-invasive and drug-free therapy for anxiety and insomnia by emitting a patented frequency-based waveform that stimulates positive responses in mid-brain structures. The company also focuses on developing Generation 2, a medical device undergoing clinical trials for addressing substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia.